益诺思股东拟询价转让3%公司股份

Group 1 - The core point of the article is that Yinos (688710.SH) has disclosed a shareholder inquiry transfer plan, indicating a significant movement in its shareholding structure [1] - The shareholder involved in this transfer is Shanghai Zhangjiang Biomedicine Base Development Co., Ltd., which plans to transfer a total of 4.2294 million shares [1] - The shares to be transferred represent 3% of the company's total share capital, highlighting a notable change in ownership [1]